Sujame Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2020
About Sujame Life Science
Sujame Life Science Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 April 2015 (Nine years and nine months 6 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jagdishkumar Patel, Sushilaben Patel, and Meet Patel serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233GJ2015PTC083047
-
Company No.
083047
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Apr 2015
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Sujame Life Science Private Limited offer?
Sujame Life Science Private Limited offers a wide range of products and services, including Multivitamin Syrup & Drops, Vitamin B Complex Syrup, Vaccines, Hepatitis B Vaccine, Syringes, Syringes for HPLC and GC, Industrial Chemicals & Supplies, Disinfectant Chemicals, Analyzers & Analytical Instruments, Colorimetric Analyzer.
Who are the key members and board of directors at Sujame Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meet Patel
|
Director | 13-Dec-2016 | Current |
|
Jagdishkumar Patel
|
Director | 29-Apr-2015 | Current |
|
Sushilaben Patel
|
Director | 29-Apr-2015 | Current |
Financial Performance of Sujame Life Science.
Sujame Life Science Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sujame Life Science?
In 2017, Sujame Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Synetech Lifescience LlpMeet Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sujame Life Science?
Unlock and access historical data on people associated with Sujame Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sujame Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sujame Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.